Finepoint Capital LP Q4 2024 Filing
Filed February 13, 2025
Portfolio Value
$1.6T
Holdings
26
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 755,000 | $442.5B | 27.02% | Put |
| 2 | QXOQXO INC | 24,933,825 | $396.4B | 24.21% | |
| 3 | IWMISHARES TR | 1,485,000 | $328.1B | 20.04% | Put |
| 4 | LBRDKLiberty Broadband Corp | 2,015,710 | $150.7B | 9.20% | |
| 5 | FWONALIBERTY MEDIA CORP DEL | 812,792 | $55.3B | 3.38% | |
| 6 | ARGXArgenx SE | 52,928 | $32.6B | 1.99% | |
| 7 | RVMDREVOLUTION MEDICINES INC | 710,260 | $31.1B | 1.90% | |
| 8 | SWTXSPRINGWORKS THERAPEUTICS INC | 748,752 | $27.1B | 1.65% | |
| 9 | ASNDASCENDIS PHARMA A/S | 184,872 | $25.5B | 1.55% | |
| 10 | MLTXMoonLake Immunotherapeutics | 447,935 | $24.3B | 1.48% | |
| 11 | SRPTSAREPTA THERAPEUTICS INC | 161,935 | $19.7B | 1.20% | |
| 12 | GLPGGALAPAGOS NV | 674,762 | $18.6B | 1.13% | |
| 13 | XNCRXENCOR INC | 660,000 | $15.2B | 0.93% | |
| 14 | CYTKCYTOKINETICS INC | 318,448 | $15.0B | 0.91% | |
| 15 | ARVNARVINAS INC | 713,778 | $13.7B | 0.84% | |
| 16 | RNAAVIDITY BIOSCIENCES INC | 391,300 | $11.4B | 0.69% | |
| 17 | PRTAPROTHENA CORP PLC | 657,071 | $9.1B | 0.56% | |
| 18 | RLAYRELAY THERAPEUTICS INC | 2,175,646 | $9.0B | 0.55% | |
| 19 | EYPTEYEPOINT PHARMACEUTICALS INC | 1,111,104 | $8.3B | 0.51% | |
| 20 | SLDBSOLID BIOSCIENCES INC | 961,251 | $3.8B | 0.23% | |
| 21 | ANNAALEANNA INC | 27,717 | $196.8M | 0.01% | |
| 22 | ANNAALEANNA INC | 490,000 | $68.6M | 0.00% | |
| 23 | —MONEYHERO LIMITED | 895,000 | $49.4M | 0.00% | |
| 24 | —LAKESHORE BIOPHARMA CO LTD | 489,999 | $48.5M | 0.00% | |
| 25 | —Marblegate Acquisition Corp | 735,000 | $25.7M | 0.00% | |
| 26 | CLDICALIDI BIOTHERAPEUTICS INC | 12,500 | $14.4M | 0.00% |